US equities
|
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by DSS, Inc.
DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination
November 02, 2026
From
DSS, Inc.
Via
ACCESS Newswire
Tickers
DSS
IBO
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
January 30, 2024
From
DSS, Inc.
Via
GlobeNewswire